| scholarly article | Q13442814 |
| P2093 | author name string | Hua Tong | |
| Xiaodong Mao | |||
| Yajun Chen | |||
| Taiping Li | |||
| Kangsheng Liu | |||
| P2860 | cites work | Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer | Q26746010 |
| Cell-free circulating tumor DNA in cancer | Q26750899 | ||
| Methylated circulating tumor DNA in blood: power in cancer prognosis and response | Q26772077 | ||
| Fragment Length of Circulating Tumor DNA | Q27308628 | ||
| Detection of circulating tumor DNA in early- and late-stage human malignancies | Q29615778 | ||
| Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors | Q34416049 | ||
| Circulating-tumor DNA as an early detection and diagnostic tool | Q34550110 | ||
| Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients | Q35212779 | ||
| Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers | Q35881722 | ||
| Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease | Q36000803 | ||
| Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis | Q36037774 | ||
| Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study | Q36229421 | ||
| Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance | Q36574146 | ||
| Autoimmunity and the clearance of dead cells | Q37704640 | ||
| Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients | Q38389809 | ||
| Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions | Q38633504 | ||
| FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor. | Q38733229 | ||
| Implementation of Next-Generation Sequencing for Hepatitis B Virus Resistance Testing and Genotyping in a Clinical Microbiology Laboratory | Q40355667 | ||
| Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer | Q40434251 | ||
| Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer. | Q47115415 | ||
| Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial | Q48105658 | ||
| Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer | Q48655131 | ||
| Quantitative analysis of the BRAF V600E mutation in circulating tumor-derived DNA in melanoma patients using competitive allele-specific TaqMan PCR. | Q53130491 | ||
| Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients. | Q54149882 | ||
| Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer. | Q55167075 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Cancer biomarkers: Written in blood | Q59091333 | ||
| Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer | Q60312883 | ||
| Delta tocotrienol in recurrent ovarian cancer. A phase II trial | Q91030033 | ||
| Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma | Q92469929 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 3225-3233 | |
| P577 | publication date | 2020-07-15 | |
| P1433 | published in | American Journal of Translational Research | Q4744272 |
| P1476 | title | Potential value of circulating tumor DNA in gynecological tumors | |
| P478 | volume | 12 |
Search more.